CesarFreytesMD
Oncology • San Antonio, TXDirector, Hematopoietic Stem Cell Transplant Program, South Texas Veterans Health Care System
Dr. Freytes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7700 Floyd Curl Dr
San Antonio, TX 78229Phone+1 210-575-3817Fax+1 210-575-4113
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1982 - 1985
VA Caribbean Healthcare SystemResidency, Internal Medicine, 1979 - 1982
University of Puerto Rico School of MedicineClass of 1979
Certifications & Licensure
FL State Medical License 2005 - 2026
TX State Medical License 1992 - 2026
MO State Medical License 1984 - 2025
TN State Medical License 1985 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers Start of enrollment: 2005 Mar 01
- Incidence and Factors Associated With the Development and Severity of Oral Mucositis Start of enrollment: 2005 May 01
- Comparative Trial of Cryotherapy Versus Caphosol Versus Saline Solution Mouth Washes for the Prevention of Oral Mucositis in Patients With Multiple Myeloma Undergoing Hematopoietic Stem Cell Transplantation Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- 164 citationsHematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin LymphomaSonali M. Smith, Linda J. Burns, Koen van Besien, Jennifer Le-Rademacher, Wensheng He
Journal of Clinical Oncology. 2013-09-01 - 138 citationsImproved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research StudyAnita D'Souza, Angela Dispenzieri, Baldeep Wirk, Mei-Jie Zhang, Jiaxing Huang
Journal of Clinical Oncology. 2015-09-14 - 12 citationsBortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardle...Robert F. Cornell, Raphael Fraser, Luciano J. Costa, Stacey Goodman, Noel Estrada-Merly
Transplantation and Cellular Therapy. 2021-03-01
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
